ciclopirox has been researched along with butenafine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bradley, M; Ghannoum, M; Griffiths, B; Kokjohn, K | 1 |
| Chiang, A; Hafeez, F; Hui, X; Kamili, F; Maibach, HI; Zhu, H | 1 |
3 other study(ies) available for ciclopirox and butenafine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
Topics: Antifungal Agents; Arthrodermataceae; Bacteria; Benzylamines; Ciclopirox; Drug Resistance, Fungal; Econazole; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Sensitivity and Specificity; Yeasts | 2003 |
Stratum corneum reservoir as a predictive method for in vitro percutaneous absorption.
Topics: Benzylamines; Cadaver; Ciclopirox; Epidermis; Humans; Ketoconazole; Linear Models; Naphthalenes; Pyridones; Skin; Skin Absorption; Terbinafine | 2016 |